New Venturist is run by Babs Carryer, a serial entrepreneur and active in multiple entrepreneurial activities.

At Carnegie Mellon University, she is Adjunct Professor of Entrepreneurship, Embedded Entrepreneur for Project Olympus where she works with faculty to commercialize innovations, Innovation Advisor at the Institute for Social Innovation, and working with the CMU/Portugal program to encourage entrepreneurship and innovation in this small European nation.

Babs co-founded LaunchCyte, which currently has five life sciences portfolio companies, including Immunetrics, which is collaborating with Philips on infectious disease, and Knopp Neurosciences, which in 2010 announced a $345M deal with Biogen to develop and commercialize a new drug for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Babs is President of Carryer Consulting which provides strategic business planning services to technology companies.

Babs teaches the Benchtop to Bedside new technology commercialization course to clinicians and researchers at the University of Pittsburgh.

Previously, Babs was director of deal flow for BlueTree Allied Angels.

She was a 2008 Bishoff Entrepreneur-in-Residence at Penn State University.

Babs has a Masters in Public Management (MPM) from the Heinz College at Carnegie Mellon. Babs attended Reed College in Portland OR, and received her BA from Mills College in Oakland CA.